PEPG logo

PEPG
PepGen Inc

1,013
Mkt Cap
$312.4M
Volume
424,547.00
52W High
$7.80
52W Low
$0.8801
PE Ratio
-1.87
PEPG Fundamentals
Price
$4.23
Prev Close
$4.52
Open
$4.48
50D MA
$5.59
Beta
1.32
Avg. Volume
631,394.61
EPS (Annual)
-$2.12
P/B
2.11
Rev/Employee
$0.00
$143.41
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG...
PR Newswire·4d ago
News Placeholder
More News
News Placeholder
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of PepGen, Inc. (NASDAQ:PEPG - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation and five have given a b...
MarketBeat·12d ago
News Placeholder
Boxer Capital Management LLC Invests $1.16 Million in PepGen, Inc. $PEPG
Boxer Capital Management LLC bought a new stake in PepGen, Inc. (NASDAQ:PEPG - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 250,000 shares of...
MarketBeat·15d ago
News Placeholder
Commodore Capital LP Invests $10.89 Million in PepGen, Inc. $PEPG
Commodore Capital LP bought a new position in shares of PepGen, Inc. (NASDAQ:PEPG - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought...
MarketBeat·15d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG...
PR Newswire·18d ago
News Placeholder
Research Analysts Offer Predictions for PepGen Q1 Earnings
PepGen, Inc. (NASDAQ:PEPG - Free Report) - Analysts at HC Wainwright increased their Q1 2026 EPS estimates for PepGen in a research note issued to investors on Thursday, March 5th. HC Wainwright...
MarketBeat·22d ago
News Placeholder
FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial
PepGen (PEPG) shifts focus to DM1 but faces a fresh FDA roadblock. Clinical data, analyst ratings, and technical support levels inside.read more...
Benzinga·25d ago
News Placeholder
PepGen (NASDAQ:PEPG) Posts Earnings Results, Beats Expectations By $0.11 EPS
PepGen (NASDAQ:PEPG - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.27) earnings per share for the quarter, beating the consensus estimate of ($0.38) by $0.11...
MarketBeat·26d ago
News Placeholder
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...
Business Wire·26d ago
News Placeholder
PepGen Announces Regulatory Updates on FREEDOM2
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies to treat severe neuromuscular and neurological diseases, today announced...
Business Wire·26d ago
<
1
2
...
>

Latest PEPG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.